Scientists are learning that Alzheimer’s disease is not only a brain problem. It can be linked to how the body handles fat, especially when a person is overweight.
Researchers at Houston Methodist studied how extra body fat can send bad signals to the brain. These signals mess up the brain’s immune system and make Alzheimer’s damage worse.
The study was led by Stephen Wong, Ph.D., and Li Yang, Ph.D., and was published in Molecular Neurodegeneration.
Fat Molecules That Connect Weight and Memory
They found a type of fat called phosphatidylethanolamine, or PE for short. PE molecules live in cell membranes all over the body.
When a person is obese, the body makes more PE. These extra PE pieces join tiny carriers that travel through the bloodstream and can reach the brain.
Inside the brain, the carriers disturb how brain cells talk to each other. They also weaken the brain’s defense system and help harmful amyloid proteins build up. Amyloid buildup is a key sign of Alzheimer’s.
"Obesity changes the signals that reach the brain," said Wong. "The good news is that we might be able to fix this process rather than just treating the disease itself."
Balancing Fat Can Help Brain Power
When the scientists restored a healthier level of PE, the brain’s lipid balance improved.
The animals in the study showed better learning, memory, attention, and problem‑solving abilities.
These results suggest that targeting the fat molecules or the pathway that carries them could lower some of the damage caused by obesity and Alzheimer’s.
A Growing Health Issue
The CDC says more than 6.5 million Americans have Alzheimer’s today. That number could rise to nearly 14 million by 2060.
Yang says more work is needed before PE‑targeted treatments can be tried in people. Still, the study offers a new way to act early for those whose weight puts them at higher risk.
Study Team and Support
The research involved scientists from Houston Methodist, the University of Texas San Antonio, Boston University, and Ohio State University.
Funding came from the Cure Alzheimer’s Fund, the T.T. and W.F. Chao Foundation, and the John S. Dunn Research Foundation.